During the past decade, Azienda Ospedaliera San Camillo Forlanini; Oncologia Medica conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera San Camillo Forlanini; Oncologia Medica" are "Bladder Cancer" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Metastatic Prostate Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Prostatic Neoplasms, Castration-Resistant" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera San Camillo Forlanini; Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera San Camillo Forlanini; Oncologia Medica" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Abiraterone" (1 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera San Camillo Forlanini; Oncologia Medica" are 5 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera San Camillo Forlanini; Oncologia Medica". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Azienda Ospedaliera San Camillo Forlanini; Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera San Camillo Forlanini; Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".